Low-Risk Prostate Cancer Treatment - MUSC Hollings
David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal cancers at MUSC Hollings Cancer Center in Charleston, SC. In this informative video he shares educational information for patients on low-risk prostate cancer treatment.
Видео Low-Risk Prostate Cancer Treatment - MUSC Hollings канала MUSC Health
Видео Low-Risk Prostate Cancer Treatment - MUSC Hollings канала MUSC Health
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Low Risk (Gleason 3+3=6) & Intermediate Risk (Gleason 3+4=7) Prostate Cancer Q+A | PCRI #13
Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings
Active Surveillance for Prostate Cancer | Prostate Cancer Staging Guide
What to Expect: Low-Risk Prostate Cancer
Focal therapy – prostate cancer treatment that doesn’t involve erectile dysfunction or incontinence
Diagnosis and treating prostate cancer: Mayo Clinic Radio
Video Q&A about Prostate Cancer
Active Surveillance for Prostate Cancer, Dr. Christopher Saigal | UCLAMDChat
Understanding The Gleason Score | Prostate Cancer Staging Guide
Making Decisions After Being Diagnosed with Early Stage Prostate Cancer | UCLAMDChat
High-Risk Prostate Cancer Treatment - MUSC Hollings
Vitamin D may keep low-grade prostate cancer from becoming aggressive
Treatments Gleason 3+4 & Gleason 4+3 Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MD
Active Surveillance for Prostate Cancer
What Is a Normal PSA for a Man Without Prostate Cancer? | Ask a Prostate Expert, Mark Scholz, MD
Diagnosis of Prostate Cancer and Active Surveillance | Answering YouTube Comments #7 | The PCRI
The 4 Types of Prostate Cancer Treatment | Prostate Cancer Staging Guide
Understanding Prostate Cancer - Intermediate Risk
Talking about PSA Testing for Prostate Cancer - 3 Patients Scenarios
IMRT vs SBRT vs Protons vs Brachytherapy | Ask a Prostate Expert, Mark Scholz, MD